Doctor Jeffrey Weitz
Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Balancing safety and efficacy of oral anticoagulation in patients with atrial fibrillation undergoing cardiac interventions
Event: ESC Congress 2019
Topic: Treatment
Session type: Practical Tutorials
Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice
Event: ESC Congress 2018
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Increasing the awareness for thrombosis: worldwide challenges and global initiatives
Event: ESC Congress 2017
Topic: Thrombosis and coagulation
Session type: Symposium
Managing patients with pulmonary embolism after hospital discharge... Considering the evidence for anticoagulation
Event: ESC Congress 2017
Topic: Acute pulmonary embolism
Session type: Satellite Symposium
The changing landscape of oral anticoagulation for atrial fibrillation
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
Emerging options for patients with atrial fibrillation
Event: ESC CONGRESS 2014
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
The changing landscape in oral anticoagulation – The last pieces of the puzzle
Event: ESC Congress 2013
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
ESC 365 is supported by
